Cargando…

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants

We compared the serum neutralizing antibody titers before and after two doses of the BNT162b2 COVID-19 vaccine in ten individuals who recovered from SARS-CoV-2 infection prior to vaccination to 20 individuals with no history of infection, against clinical isolates of B.1.1.7, B.1.351, P.1, and the o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leier, Hans C., Bates, Timothy A., Lyski, Zoe L., McBride, Savannah K., Lee, David X., Coulter, Felicity J., Goodman, James R., Lu, Zhengchun, Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095208/ https://www.ncbi.nlm.nih.gov/pubmed/33948601 http://dx.doi.org/10.1101/2021.04.25.21256049

Ejemplares similares

Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
por: Bates, Timothy A., et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

Lipids and pathogenic flaviviruses: An intimate union
por: Leier, Hans C., et al.
Publicado: (2018)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

A lyophilized colorimetric RT-LAMP test kit for rapid, low-cost, at-home molecular testing of SARS-CoV-2 and other pathogens
por: Song, Xin, et al.
Publicado: (2022)

Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype
por: Nix, Chad D., et al.
Publicado: (2020)

SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern.
por: Lyski, Zoe L., et al.
Publicado: (2021)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection
por: Lyski, Zoe L., et al.
Publicado: (2019)

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
por: Garziano, Micaela, et al.
Publicado: (2022)

Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings
por: Thomas, Archana, et al.
Publicado: (2021)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages
por: Wang, Lei, et al.
Publicado: (2022)

Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
por: Zhu, Yuqi, et al.
Publicado: (2022)

Dynamics of Serum-Neutralizing Antibody Responses in Vaccinees through Multiple Doses of the BNT162b2 Vaccine
por: Sheehan, Jared, et al.
Publicado: (2023)

Longitudinal analysis of anti-SARS-CoV-2 neutralizing antibody (NAb) titers in vaccinees using a novel giant magnetoresistive (GMR) assay
por: Ng, Elaine, et al.
Publicado: (2023)

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
por: Lyski, Zoe L., et al.
Publicado: (2022)

Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy
por: Adhikari, Emily H., et al.
Publicado: (2023)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees
por: Liu, Binjian, et al.
Publicado: (2022)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation
por: Mileto, D., et al.
Publicado: (2022)

Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection
por: Abou-Saleh, Haissam, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8(+) and CD4(+) T cells of broad specificity
por: Lim, Joey Ming Er, et al.
Publicado: (2022)

A global lipid map defines a network essential for Zika virus replication
por: Leier, Hans C., et al.
Publicado: (2020)

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants
por: Farley, Scotland E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sodp1qrprk3202ecn7c5phpdpq